VASCONCELLES MICHAEL
Insider CIK 1734755 · KURA Director · UMRX Chief Medical Officer · MGTA Director · DAWN Head of Research and Dev. · IMGN EVP R&D & MEDICAL AFFAIRS
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KURA Kura Oncology, Inc. | A Award deriv | 2026-06-04 | 2026-06-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 346,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 171,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 106,875 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer deriv | 2026-04-23 | 2026-04-23 | 226,000 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | D To issuer | 2026-04-23 | 2026-04-23 | 4,397 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2026-02-17 | 2026-02-18 | 2,728 | $11.60 | $31.6K | 4,397 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise deriv | 2026-02-15 | 2026-02-18 | 7,125 | — | $0 | 106,875 | SEC↗ |
| DAWN Day One Biopharmaceuticals | M Exercise | 2026-02-15 | 2026-02-18 | 7,125 | — | $0 | 7,125 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2026-01-30 | 2026-01-30 | 171,000 | — | $0 | 171,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2026-01-30 | 2026-01-30 | 114,000 | — | $0 | 114,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-16 | 2025-06-18 | 226,000 | — | $0 | 226,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | A Award deriv | 2025-06-16 | 2025-06-18 | 346,000 | — | $0 | 346,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 28,500 | — | $0 | 28,500 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2024-09-13 | 2024-09-17 | 17,333 | — | $0 | 17,333 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2024-09-13 | 2024-09-17 | 52,000 | — | $0 | 52,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 960,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,515 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer | 2024-02-12 | 2024-02-12 | 1,327 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 50,515 | — | $0 | 50,515 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award | 2023-12-29 | 2024-01-03 | 1,327 | $16.01 | $21.2K | 1,327 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-12-29 | 2023-01-03 | 960,000 | — | $0 | 960,000 | SEC↗ |
| MGTA Magenta Therapeutics, Inc. | A Award deriv | 2022-08-15 | 2022-08-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| UMRX Unum Therapeutics Inc. | A Award deriv | 2019-03-01 | 2019-04-11 | 61,900 | — | $0 | 61,900 | SEC↗ |